Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 306-312

  Kwaan, H C ^a,b   Wang, J ^a   Weiss, I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Annexin II; Plasmin generation; t PA; u PA; u PA receptor

Indexed keywords

ALTEPLASE; ANTIBODY; CELL RECEPTOR; HEPARIN; LIPOCORTIN 2; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; UROKINASE; CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; AORTA; ARTICLE; BLEEDING TENDENCY; BLOOD CLOT LYSIS; BRAIN CORTEX; BRAIN HEMORRHAGE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; ILIAC ARTERY; ILIAC VEIN; LUNG; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SKIN; WESTERN BLOTTING; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANNEXIN A2; CELLS, CULTURED; CEREBRAL CORTEX; ENDOTHELIUM, VASCULAR; HEPARIN; HUMANS; ORGAN SPECIFICITY; PLASMIN; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 4644219614     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.00593.x     Document Type: Article

References (26)

1. Hajjar KA, Menell JS. Annexin II: a novel mediator of cell surface plasmin generation. Ann NY Acad Sci 1997; 811: 337-49.
2. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999; 340: 994-1004.
3. Blasi F. Surface receptors for urokinase plasminogen activator. Fibrinolysis 1988; 2: 73-84.
4. Nielsen LS, Kellerman GM, Behrendt N, Picone R, Dano K, Blasi F. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. J Biol Chem 1988; 263: 2358-63.
5. Ploug M, Behrendt N, Lober D, Dano K. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator. Sem Throm Hemost 1991; 17: 183-93.
6. The Continuous Infusion Versus Double-Bolus Administration of Alteplase (COBALT) Investigators. A comparison of continuous infusion of Alteplase with double bolus administration for acute myocardial infarction. N Engl J Med 1997; 337: 1124-30.
7. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated factors. Chest 1997; 111: 1241-5.
8. The NINDS tPA Stroke Study Group. Intracerebral hemorrhage after intravenous tPA therapy for ischemic stroke. Stroke 1998; 28: 2109-18.
9. Hacke W, Kaste M, Fieschi C, Toni D, Lasaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahange MH. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ENCASS). JAMA 1995; 274: 1017-25.
10. Chandler WL, Alessi MC, Aillaud ME, Henderson P, Vague P, Juhan-Vague I. Clearance of tissue plasminogen activator (tPA) and tPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated tPA antigen in patients with high PAI-1 activity levels. Circulation 1997; 96: 761-8.
11. Tabengwa EM, Abou-Agag LH, Benza RL, Torres JA, Aikens ML, Booy FM. Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells. Alcohol Clin Exp Res 2000; 24: 754-61.
12. Barlow GH, Francis CW, Marder VJ. On the conversion of high molecular weight urokinase to low molecular weight form by plasmin. Throm Res 1981; 23: 541-7.
13. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-7.
14. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator. II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994; 269: 21198-203.
15. Rosenfeld R, Kuo A, Hirsh J, Heparin enhances active-site dependent binding of tissue type plasminogen activator to endothelial cells. Blood 1992; 80: 1486-95.
16. Metz BK, Topol EJ. Heparin as an adjunct to thrombolytic therapy in acute myocardial infarction. Biomed Pharmacother 1996; 50: 243-53.
17. Strickland S. Tissue plasminogen activator in nervous system function and dysfunction. Thromb Haemost 2001; 86: 138-43.
18. Basham ME, Seed NW. Plasminogen expression in neonatal and adult mouse brain. J Neurochem 2001; 77: 318-25.
19. Seeds NW, Haffke S, Christensen K, Schoonmaker J. Cerebellar granule cell migration involves proteolysis. Adv Exp Med Biol 1990; 265: 169-78.
20. Sumi Y, Dent MA, Owen DE, Seeley PJ, Morris RJ. The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development 1992; 116: 625-37.
21. Dent MA, Sumi Y, Morris RJ, Seeley PJ. Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain. Eur J Neurosci 1993; 5: 633-47.
22. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 1993; 36 453-7.
23. Jacovina At Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem 2001; 276: 49350-8.
24. Davies BJ, Pickard BS, Steel M, Morris RG, Lathe R. Serine proteases in rodent hippocampus. J Biol Chem 1998; 273: 23004-11.
25. Rudd MA, Johnstone MT, Rabbani LE, George D, Ware JA, Loscalzo J. Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin. Circulation 1991; 84: 2568-73.
26. Okajima K, Abe H, Binder BR. Endothelial cell injury induced by plasmin in vitro. J Lab Clin Med 1995; 126: 377-84.